• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Model Number ESBF2314C103E
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Numbness (2415); Obstruction/Occlusion (2422)
Event Date 09/15/2020
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: other relevant device(s) are: product id: e tlw1616c124e, serial/lot #: (b)(4), ubd: 23-mar-2022, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Endurant stent grafts etuf2314c102, etlw1616c146e and etlw1613c82e were implanted for the treatment of thrombus in the previously implanted esbf2314c103e and etlw1616c124e devices (approximately 3 years previous).A fem fem bypass was also completed during the original index procedure.Approximately 2 years post the original index procedure intervention was completed for thrombus and occlusion and the patient had been on anti-coagulation medication since this time.Approximately 3 years post the original index procedure the patient presented with right leg pain and angiogram showed evidence of thrombus within the previously implanted esbf2314c103e and etlw1616c124e devices and etuf2314c102, etlw1616c146e and etlw1613c82e were implanted.Thrombectomy was performed on the same day, the esbf2314c103e and etlw1616c124e were re-lined with an etuf2314c102 and etlw1616c146e with the placement of an etlw1613c82e to extend into the external right iliac.Thrombectomy was also performed on the previous femoral-femoral bypass and femoral-popliteal bypass.During the angiogram post implant of the etuf2314c102e it was noted that the left renal artery appeared to be occluded, thrombectomy was performed with implantation of a covered balloon expandable stent.Angiogram then revealed flow in the left renal artery.Per the physician, the thrombus development was possible due to an outflow issue in the femoral-popliteal bypass and femoral-femoral bypass.It was reported the cause of the renal artery occlusion was due to thrombus from the aorta which embolized to the left renal during the implant of the endurant aui or during post implant ballooning.No additional clinical sequalae were reported and the patient is fine.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT IIS BIFURCATED STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key12405536
MDR Text Key269632620
Report Number9612164-2021-03364
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00643169439993
UDI-Public00643169439993
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/27/2020
Device Model NumberESBF2314C103E
Device Catalogue NumberESBF2314C103E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/04/2021
Initial Date FDA Received09/01/2021
Supplement Dates Manufacturer Received11/04/2021
Supplement Dates FDA Received11/08/2021
Date Device Manufactured02/27/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age49 YR
Patient SexMale
-
-